Displaying drugs 226 - 250 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Lebrikizumab | Not Available |  | An IgG4 monoclonal antibody against IL-13 used to treat moderate-to-severe atopic dermatitis in adults and adolescents. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Lecanemab | 150000.0 C6544H10088N1744O2032S46 | | An amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology. | Alzheimer Disease / Alzheimer Disease, drug therapy / Amino Acids, Peptides, and Proteins / Amyloid Beta-directed Antibodies / Antibodies / Antibodies, Monoclonal / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Lenograstim | Not Available | | A granulocyte colony-stimulating factor indicated in the reduction of duration of neutropenia in bone marrow transplant and cytotoxic chemotherapy, as well as mobilizing hematopoietic stem cells in healthy donors. | Colony-Stimulating Factors |
| Lepirudin | 6979.0 C287H440N80O111S6 |  | A protein-based direct thrombin inhibitor used as an anticoagulant in patients with heparin-induced thrombocytopenia. | Anticoagulants / Antithrombins |
| LetibotulinumtoxinA | Not Available | | A purified type A botulinum neurotoxin protein complex used to improve the appearance of glabellar lines. | Botulinum Toxins, Type A / Central Nervous System Depressants / Neuromuscular Agents / Neuromuscular Blocking Agents |
| Lipegfilgrastim | 39000.0 C866H1372N226O258S9*(C2H4O)n |  | A medication used to reduce the duration of chemotherapy-induced neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy. | Colony-Stimulating Factors |
| Liraglutide | 3751.2 C172H265N43O51 | | A GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes. | Glucagon-like peptide-1 (GLP-1) analogues |
| Lixisenatide | 4858.0 | | A GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Loncastuximab tesirine | 151000.0 | | An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas. | Antineoplastic Agents, Immunological |
| Lucinactant | 2470.2 C 126 H 238 N 26 O 22 | | Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | Pulmonary Surfactants |
| Luspatercept | 76000.0 | | An erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. | Hematinics |
| Luteinizing hormone | Not Annotated | | Not Annotated | Gonadotropins, Pituitary |
| Lutropin alfa | 30000.0 C1014H1609N287O294S27 |  | A form of recombinant human luteinizing hormone used to treat female infertility due to hypothalamic or pituitary insufficiency, or due to profound luteinizing hormone deficiency. | Gonadotropins |
| Lyme disease vaccine (recombinant OspA) | 27743.1 C1198H2012N322O422S2 |  | For prophylactic treatment of Lyme Disease | Not Available |
| Maftivimab | 143948.11 C6368H9886N1706O2008S46 | | Part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells. | Antiviral Agents |
| Mecasermin | 7649.0 C331H518N94O101S7 |  | A recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH. | Somatropin and Somatropin Agonists |
| Mecasermin rinfabate | Not Available | | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... | Somatropin and Somatropin Agonists |
| Menotropins | 23390.3 C1014H1609N287O294S27 |  | A purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility. | Biological Products / Fertility Agents, Female / Gonadotropins / Gonadotropins, Pituitary |
| Mepolizumab | 149000.0 |  | A fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. | Interleukin-5 Antagonist |
| Methoxy polyethylene glycol-epoetin beta | Not Available | | A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. | Erythropoiesis-Stimulating Agents |
| Metreleptin | 16155.4429 C714H1167N191O221S6 |  | A leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy. | Amino Acids and Derivatives |
| Mirikizumab | 147000.0 | | An anti-IL-23 monoclonal antibody used as a second-line therapy for moderate-to-severe active ulcerative colitis. | Anti-Ulcer Agents / Gastrointestinal Agents |
| Mirvetuximab soravtansine | 150000.0 | | A folate receptor alpha-directed antibody and microtubule inhibitor conjugate used to treat folate receptor alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibody-drug Conjugates / Antineoplastic Agents / Blood Proteins / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoconjugates / Immunoglobulins / Immunologic Factors / Immunoproteins / Lactams, Macrocyclic / Lactones / Microtubule Inhibition / P-glycoprotein substrates / Proteins / Serum Globulins |
| Mogamulizumab | Not Available | | A monoclonal antibody used to treat relapsed or refractory mycosis fungoides or Sézary syndrome after attempting one other therapy. | Antibodies, Monoclonal / Chemokine Receptor Type 4 Interaction |
| Moroctocog alfa | 173000.0 | | A recombinant Factor VIII used to treat hemophilia A to control bleeding. | Recombinant Proteins |
Displaying drugs 226 - 250 of 406 in total